IP Library › Assignment 022380/0239
Patent Assignment
Reel/Frame 022380/0239

Change of Name

Recorded: 2009-03-09 Pages: 5
Assignor
Assignee
CELLDEX THERAPEUTICS, INC.
119 FOURTH AVENUE, NEEDHAM, MASSACHUSETTS, 02494
Covered Properties (30)
Treatment for Age-Related Macular Degeneration and Other Diseases of the Eye
V. Cholerae Hyperexpressing Recombinant Cholera Toxin B Subunit Showing Dual Immunogenicity
Nucleic Acids Encoding a Human C3B/C4B Receptor (CR1)
Patent: 5,212,071 →
Application: 07/332,865 →
Compositions of Soluble Complement Receptor 1 (Cr 1) and a Thromboltic Agent, and the Methods of Use Thereof
Patent: 5,256,642 →
Application: 07/588,128 →
Protein Purification
Patent: 5,252,216 →
Application: 07/857,022 →
Glycoform Fractions of Recombinant Soluble Complement Receptor 1(SCR1) Having Extended Half-Lives in Vivo
Patent: 5,456,909 →
Application: 07/927,099 →
Method of Treating Complement Mediated Disorders
Patent: 5,472,939 →
Application: 08/138,825 →
Modulation of Cholesteryl Ester Transfer Protein (Cetp) Activity
Patent: 6,410,022 →
Application: 08/432,483 →
Compositions Comprising Complement Receptor Type 2 Molecules Having Carbohydrate Structures That Are Slectin Ligands
Patent: 6,193,979 →
Application: 08/450,274 →
Human C3B/C4B Receptor (CR1)
Patent: 6,316,604 →
Application: 08/463,959 →
The Human C3B/C4B Receptor (CR1)
Patent: 5,981,481 →
Application: 08/470,652 →
Theapeutic Methods Employing Sialylated Glycoforms of Soluble Complement Recptor 1 (Scri)
Patent: 5,858,969 →
Application: 08/470,867 →
The Human C3B/C4B Receptor (CR1)
Patent: 5,856,297 →
Application: 08/472,038 →
Compositions Comprising Complement Related Proteins and Carbohydrates, and Methods for Producing and Using Said Compositions
Patent: 5,856,300 →
Application: 08/553,339 →
Protein Purification Using Immobilized Metal Affinity Chromatography for Complement Receptor Proteins
Patent: 5,840,858 →
Application: 08/581,604 →
Pulmonary Administration of SCR1 and Other Complement Receptor-1 (SCR1) and Its Derivatives
Patent: 6,169,068 →
Application: 08/602,761 →
Recombinant Bacterial System with Environmentally Limited Viability
Patent: 6,610,529 →
Application: 08/761,769 →
Modulation of Cholesteryl Ester Transfer Protein (Cetp) Activity
Patent: 6,555,113 →
Application: 08/945,289 →
Recombinant Bacterial Vaccine System with Environmentally Limited Viability
Patent: 7,871,604 →
Application: 09/120,970 →
Method for Increasing Hdl Cholesterol Level
Patent: 7,074,407 →
Application: 09/523,033 →
Regulated Antigen Delivery Sysem (Rads)
Patent: 6,780,405 →
Application: 09/560,539 →
Method of Using Sfv HUTAT2 in Intracellular Targeting Generation of Ln-Hsfvtat Packaging Cell Lines
Patent: 6,479,284 →
Application: 09/660,169 →
Plasmid-Based Vaccine for Treating Atherosclerosis
Patent: 6,846,808 →
Application: 09/845,511 →
Modulation of Cholesteryl Ester Transfer Protein (Cetp) Activity
Patent: 7,078,036 →
Application: 09/943,334 →
Publication: US 2004/0087481
Modulation of cholesteryl ester transfer protein (CETP) activity
Application: 10/339,522 →
Publication: US 2003/0108559
Vaccination against anthrax
Application: 10/479,770 →
Publication: US 2004/0166120
Recombinant bacterial system with environmentally limited viability
Application: 10/620,777 →
Publication: US 2004/0208897
Regulated Antigen Delivery System (Rads)
Patent: 7,341,860 →
Application: 10/924,574 →
Publication: US 2005/0106176
Use of complement inhibitory proteins to treat spinal cord injury
Application: 11/173,310 →
Publication: US 2007/0004625
Modulation of cholesteryl ester tranfer protein (cetp) activity
Application: 11/920,892 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest. Apr 4, 1990
From: KLICKSTEIN, LLOYD B.; WONG, WINNIE W.
To: JOHNS HOPKINS UNIVERSITY, THE, A CORP. OF MARYLAND; BRIGHAM AND WOMEN'S HOSPITAL, THE, A CORP. OF MASSACHUSETTS; T CELL SCIENCES, INC., A DELAWARE CORP.
Reel/Frame 005277/0195 →
Assignment of Assignors Interest. Apr 4, 1990
From: CARSON, GERALD R.; CONCINO, MICHAEL F.; IP, STEPHEN H.; MAKRIDES, SAVVAS C.
To: JOHNS HOPKINS UNIVERSITY, THE, A CORP. OF MARYLAND; BRIGHAM AND WOMEN'S HOSPITAL, THE, A MASSACHUSETTS CORP.; T CELL SCIENCES, INC., A DELAWARE CORP.
Reel/Frame 005277/0201 →
Assignment of Assignors Interest. Apr 4, 1990
From: FEARON, DOUGLAS T.
To: JOHNS HOPKINS UNIVERSITY, THE, A CORP. OF MARYLAND; BRIGHAM AND WOMEN'S HOSPITAL, THE, A MASSACHUSETTS CORP.; T CELL SCIENCES, INC., A DELAWARE CORP.
Reel/Frame 005277/0207 →
Assignment of Assignors Interest. Nov 21, 1990
From: KLICKSTEIN, LLOYD B.; WONG, WINNIE W.
To: JOHNS HOPKINS UNIVERSITY, THE; BRIGHAM AND WOMEN'S HOSPITAL, THE; T CELL SCIENCES, INC.
Reel/Frame 005536/0518 →
Assignment of Assignors Interest. Nov 21, 1990
From: CARSON, GERALD R.; CONCINO, MICHAEL F.; IP, STEPHEN H.; MAKRIDES, SAVVAS C.
To: JOHNS HOPKINS UNIVERSITY, THE; BRIGHAM AND WOMEN'S HOSPITAL, THE; T CELL SCIENCES, INC.
Reel/Frame 005536/0525 →
Assignment of Assignors Interest. Nov 21, 1990
From: FEARON, DOUGLAS T.
To: JOHNS HOPKINS UNIVERSITY, THE; BRIGHAM AND WOMEN'S HOSPITAL, THE; T CELL SCIENCES, INC.
Reel/Frame 005536/0511 →
Assignment of Assignors Interest. Mar 24, 1992
From: FOLENA-WASSERMAN, GAIL; O'GRADY, JOHN H.; SMITH, THOMAS M.
To: SMITHKLINE BEECHAM CORPORATION, A CORP. OF PA
Reel/Frame 006068/0737 →
Assignment of Assignor's Interest Jan 7, 1993
From: MARSH, HENRY C., JR.; GOSSELIN, MICHAEL L.; LIFTER, JOHN
To: T CELL SCIENCES, INC.; SMITHKLINE BEECHAM P.L.C.
Reel/Frame 006537/0552 →
Assignment of Assignor's Interest Jan 7, 1993
From: YEH, CHANG-JING GRACE
To: T CELL SCIENCES, INC.; SMITHKLINE BEECHAM P.L.C.
Reel/Frame 006537/0564 →
Assignment of Assignor's Interest Jan 7, 1993
From: SMITH, RICHARD A. G.; FREEMAN, ANNE M.
To: T CELL SCIENCES, INC.; SMITHKLINE BEECHAM P.L.C.
Reel/Frame 006537/0559 →
Assignment of Assignor's Interest May 1, 1995
From: RITTERSHAUS, CHARLES W.
To: T CELL SCIENCES, INC.
Reel/Frame 007506/0476 →
Assignment of Assignor's Interest Apr 8, 1996
From: SMITH, THOMAS MICHAEL; FOLENA-WASSERMAN, GAIL
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 007891/0205 →
Assignment of Assignor's Interest Feb 10, 1997
From: CURTISS, ROY III; TINGE, STEVEN A.
To: WASHINGTON UNIVERSITY
Reel/Frame 008413/0682 →
(Assignment of Assignor's Interest) Re-Record to Correct the Number of Microfilm Pages from 3 to 5. an Assignment Was Previously Recorded at Reel 8568, Frame 0512. Apr 15, 1997
From: SMITHKLINE BEECHAM CORPORATION
To: T CELL SCIENCES, INC.
Reel/Frame 008732/0058 →
Assignment of Assignor's Interest Apr 15, 1997
From: SMITHKLINE BEECHAM CORPORATION
To: T CELL SCIENCES, INC.
Reel/Frame 008568/0512 →
Assignment of Assignor's Interest Oct 17, 1997
From: RITTERSHAUS, CHARLES W.; THOMAS, LAWRENCE J.
To: T CELL SCIENCES, INC.
Reel/Frame 008942/0406 →
Assignment of Assignor's Interest Jan 20, 1998
From: RITTERSHAUS, CHARLES W.; TOTH, CAROL A.
To: T CELL SCIENCES, INC.
Reel/Frame 008962/0596 →
Change of Name Jul 14, 1999
From: T CELL SCIENCES, INC, (NEEDHAM, MASSACHUSETTS)
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 010086/0348 →
Change of Name Sep 15, 1999
From: T CELL SCIENCES, INC. (NEEDHAM, MASSACHUSETTS)
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 010238/0102 →
Assignment of Assignor's Interest Dec 14, 2000
From: MARASCO, WAYNE A.; LAVECCHIO, JOYCE; MHASHILKAR, ABNER M.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 011340/0597 →
Assignment of Assignor's Interest Dec 14, 2000
From: DAVID, RING
To: CHIRON CORPORATION
Reel/Frame 011340/0618 →
Assignment of Assignor's Interest Jun 15, 2001
From: RAMSTEDT, URBAN; EBERHARDT, BRIDGET; PORTER-BROOKS, JULIE
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 011901/0711 →
Assignment of Assignor's Interest Sep 21, 2001
From: THE IMMUNE RESPONSE CORPORATION
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 011985/0567 →
Assignment of Assignor's Interest Sep 16, 2002
From: JAESCHKE, MANFRED; SCHLEY, PETER; VAN ROSMALE, JANSSEN RENEE; SCHOUTEN, JAN A.
To: RUHRGAS AKTIENGESELLSCHAFT; N.V. NEDERLANDSE GASUNIE
Reel/Frame 013838/0075 →
Assignment of Assignor's Interest Jan 20, 2004
From: WASHINGTON UNIVERSITY
To: AVANT IMMUNOTHERAPEUTICS, INC.
Reel/Frame 014271/0664 →